Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
39.72B | 41.42B | 39.41B | 33.77B | 37.72B | Gross Profit |
8.80B | 8.81B | 8.31B | 7.74B | 8.59B | EBIT |
852.00M | 799.60M | 1.33B | 1.79B | -317.60M | EBITDA |
4.43B | 4.26B | 4.01B | 4.11B | 2.46B | Net Income Common Stockholders |
1.17B | 1.16B | 112.20M | 1.44B | -918.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.72B | 2.92B | 2.44B | 2.00B | 2.64B | Total Assets |
36.97B | 37.75B | 37.93B | 35.84B | 39.64B | Total Debt |
6.91B | 7.17B | 7.67B | 6.24B | 7.32B | Net Debt |
3.94B | 4.25B | 5.23B | 4.24B | 4.68B | Total Liabilities |
22.17B | 23.63B | 24.19B | 23.20B | 27.00B | Stockholders Equity |
14.35B | 13.68B | 13.26B | 12.19B | 12.26B |
Cash Flow | Free Cash Flow | |||
996.00M | 1.18B | 126.30M | 1.08B | 587.90M | Operating Cash Flow |
2.93B | 3.33B | 2.30B | 2.95B | 2.71B | Investing Cash Flow |
-1.82B | -2.17B | -2.20B | -1.58B | -1.84B | Financing Cash Flow |
-1.07B | -1.13B | 653.50M | -1.16B | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $50.49B | 7.75 | 7.02% | 7.13% | -10.13% | -37.28% | |
75 Outperform | $213.91B | 32.98 | 17.20% | 1.25% | 0.78% | 6.75% | |
75 Outperform | €173.67B | 18.16 | 14.18% | 2.32% | -1.13% | 8.98% | |
73 Outperform | €51.43B | 5.46 | 5.52% | 8.96% | 1.62% | -38.38% | |
61 Neutral | $6.93B | 11.84 | 2.89% | 3.91% | 2.59% | -21.68% | |
61 Neutral | $14.86B | 11.53 | 10.07% | 3.17% | -14.83% | 78.73% | |
59 Neutral | €39.83B | 53.90 | 2.02% | 7.58% | -2.04% | 2258.97% |